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Ossifying ﬁbromyxoid tumor (OFMT) is a rare soft tissue tumor of uncertain histogenesis, occurring
predominantly in deep soft tissues of the extremities. Typically, OFMT presents in adults on the
extremities or trunk, as a deep soft tissue mass. Less appreciated is the fact that OFMT may also present
as a mass in the superﬁcial subcutis or dermis. We herein report a female who presented with an
asymptomatic subcutaneous nodule on the left thigh for 3 years, and who was diagnosed as having
typical ossifying ﬁbromyxoid tumor, by unique histopathologic and immunohistochemical studies. Most
reported cases have pursued a benign clinical course. However, recent literature emphasized the exis-
tence of morphologically atypical and clinically malignant cases of OFMTs. Pathologic criteria for
malignancy have been proposed, and reclassiﬁcation of these tumors as tumors of intermediate malig-
nancy, raise our attention while coping with OFMT clinically.
Copyright  2012, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Ossifying ﬁbromyxoid tumor (OFMT) is a rare tumor and was ﬁrst
described by Enzinger et al1 in 1989, based on 59 cases culled from
the archives of the Armed Forces Institute of Pathology over a 25
year period. Most cases arise from subcutaneous or intramuscular
parts of the lower extremities, and only about 11% cases involved
the superﬁcial skin tissue such as the dermis.2 Clinically, OFMT
usually presents as a solitary, ﬁrm, well-deﬁned, slowly growing,
painless deep soft tissue or subcutaneous mass.3,4 Histologically,
the typical tumor is characterized by a ﬁbrous, encapsulated,
lobulated neoplasm, with a peripheral rim of bony component. It is
composed of a cord- or nest-like arrangement of round, oval, or
spindle-shaped uniform cells with vesicular nuclei.5 Therefore,
OFMT should be considered in the differential diagnosis of cuta-
neous bone-forming tumors.6Case report
A 30-year-old female presented with a well-circumscribed, ﬁrm,
asymptomatic subcutaneous mass of her left thigh (Figure 1). It wasghua City, Changhua County
iwanese Dermatological Associatioenlarging slowly over the past 3 years. No speciﬁc past medical
history or family history were obtained according to her statement.
An excisional biopsy was performed under the impression of der-
matoﬁbroma or other adnexal tumors.
Grossly, a tumor measuring 0.6  0.5  0.4 cm in size at the
superﬁcial subcutis was noted. Microscopically, it revealed a well-
deﬁned, encapsulated tumor with a ﬁbrous capsule and a focal
existence of lamellar bone component (Figures 2A,2B). Uniform,
round to ovoid cells, with eosinophilic cytoplasm, were arranged in
a cord- or nest-like pattern within a homogenous ﬁbromyxoid
stroma (Figure 3). The nuclei were relatively uniform and vesicular,
without any evidence of pleomorphism, hypercellularity, or
necrosis. There was no mitosis noted (Figure 4). An immunohisto-
chemical study revealed positive results for S-100 (Figure 5) and
negative results for CK and CD34. Scattered tumor cells were
positive for SMA. A diagnosis of ossifying ﬁbromyxoid tumor was
made. The patient underwent surgical wide excision about 1month
later. The postoperative course was uneventful. We suggested
regular follow-up afterwards.
Discussion
OFMT was ﬁrst described by Enzinger et al in 1989 as a rare deep
soft tissue tumor of uncertain differentiation.1 OFMT usually occurs
in adults, with a male predominance (M:F ratio ¼ 1.5:1).7 Mostn. Published by Elsevier Taiwan LLC. All rights reserved.
Figure 1 A 30-year-old female presented with a well-circumscribed, ﬁrm, asymp-
tomatic subcutaneous mass on her left thigh.
Figure 3 Uniform, round to ovoid cells with eosinophilic cytoplasm were arranged in
cord- or nest-type pattern within a homogeneous ﬁbromyxoid stroma (hematoxylin
and eosin stain, 100).
C.-C. Chen et al. / Dermatologica Sinica 31 (2013) 32e34 33cases involved lower extremities, followed by trunk, upper
extremities, and the head and neck region. Cutaneous OFMT is
characterized, clinically, by a circumscribed, long-standing,
asymptomatic, ﬁrm, and slowly enlarging mass, and histologically
by a well-encapsulated lobular architecture, with round to ovoid
uniform cells arranged in cord and nest patterns, within collage-
nous tomyxocollagenous stroma, usually demonstrating peripheral
focal spicules of metaplastic bone component. Small satellite tumor
nodules outside the main tumor were sometimes noted, and these
were also surrounded by a well-deﬁned ﬁbrous capsule, which
developed later.
Although Enzinger emphasized its indolent, slowly growing
natural course and benign behavior, several subsequent reports
have documented, both histologically and clinically, atypical to
malignant variants of OFMT. Yoshida et al ﬁrst reported a tumor
that lacked overtly malignant features, but produced local recur-
rence, distant soft tissue metastasis, and death.5 Soldano et al re-
ported a case of subcutaneous OFMT which recurred 8 years after
initial resection, with aggressive histologic change, such as a high
mitotic rate and cell atypia compared to the primary lesion.6 Sue-
hiro et al reported a case with a huge metastatic OFMT occupying
the upper mediastinum and upper half of the right hemithorax,
who died 8 months later after surgery, due to multiple brain and
opposite lung metastasis.8 Folpe and Weiss performed a retro-
spective review of 70 cases of OFMT; they focused on the atypical
and malignant cases related with clinical malignant behavior, such
as local recurrence and distant metastasis, over the mean follow-up
duration of 57 months.2 The presence of high cellularity or high
nuclear grade, with mitotic activity >2 mitotic ﬁgures per 50 high
power ﬁelds (HPFs) revealed a statistically signiﬁcant potential forFigure 2 (A) A well-deﬁned, encapsulated superﬁcial subcutis tumor with ﬁbrous capsule a
a chip of woven bone was present at the peripheral portion of the tumor (hematoxylin anmalignant behavior and should be subclassiﬁed into the group of
malignant OFMT, which revealed 60% local recurrence rate and 60%
metastasis rate.2 A malignant OFMT should be regarded as
a sarcoma, due to its highly aggressive clinical behavior. Even in
typical OFMTcases, overall recurrence andmetastatic rates,17% and
5%, respectively, make us consider them as lesions of intermediate
malignancy.2 Recurrence of typical OFMT usually occurred >10
years after primary excision, highlighting its low growth rate.9 A
conservative approach for conventional typical OFMT, such as
complete excision with a margin of normal tissue and long-term
follow-up, is considered optimal nowadays. In the Folpe and
Weiss classiﬁcation, those deviating from typical OFMTs, but falling
short of proposed criteria for malignant OFMTs, were labeled as
“atypical OFMTs”, which possessed a 13% local recurrence rate and
a 6% metastasis rate.
The histologic differential diagnosis of cutaneous OFMT includes
cutaneousmixed tumor (chondroid syringoma), myoepithelioma of
skin and soft tissues, extraskeletal osteosarcoma, and extraskeletal
myxoid chondrosarcoma. Cutaneous mixed tumors and myoepi-
theliomas also contain strands, nests and a reticular pattern of
bland tumor cells within a hyaline myxoid stroma. Furthermore,
calciﬁcation and ossiﬁcation are not uncommon in both tumors.
The presence of a ductal/epithelial component in mixed tumors,
which is absent in OFMT, and immunoreactivity for cytokeratin or
calponin in mixed tumor and myoepithelioma, can be useful innd focal existence of woven bony component (hematoxylin and eosin stain, 20); (B)
d eosin stain, 400).
Figure 4 The nuclei were relatively uniform and vesicular without any evidence of
pleomorphism, hypercellularity, or necrosis. No mitotic activity was noted (hematox-
ylin and eosin stain, 400).
Figure 5 Immunohistochemical study revealed immunoreactivity for S-100 protein
(400).
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neoplastic cells, the characteristic features of basophilic chon-
dromyxoid stroma, more abundant vacuolated cytoplasms and
rarely, ossiﬁcation in extraskeletal myxoid chondrosarcoma, are
different from the OFMT. Cutaneous extraskeletal osteosarcoma is
very rare. The unequivocal presence of osteoid, usually accompa-
nying high-grade nuclei of tumor cells, is essential for the diagnosisof osteosarcoma. The OFMT lacks osteoid andmostly contains bland
tumor cells.
The lineage of differentiation is uncertain. Nerve sheath and
cartilaginous origin were commonly suggested differentiation
types according to some immunohistochemical and ultrastructural
studies,10,11 but are still not conclusively proven. All typical OFMT
are immunoreactive for vimentin (100%), and 94% immunoreac-
tivity for S-100 has been reported.7 Other variable immunoreac-
tivities include CD10 (79%), pancytokeratin (13%), collagen IV (13%),
desmin (10%), and smooth muscle actin (2%).7 However, S-100
protein positivity was found to be lower in some studies, especially
those which included atypical and malignant cases. It has been
suggested that loss of S100 protein may be related to malignant
transformation.2,7 However, some experts proposed the possibility
that malignant OFMT may be fundamentally different from typical
OFMT.9
In summary, we present a case of OFMT located in the superﬁcial
subcutis. OFMT typically presents as a mass in the deep soft tissue
and is less appreciated in the superﬁcial subcutis or dermis.9
Besides, according to the reported literatures, persistent follow up
for local recurrence is needed even without any evidence of pleo-
morphism, hypercellularity, or necrosis in the primary lesion.
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